Evidence map›Paper›PMID 30862798›Full record

ArticleNature communications2019

Homozygous frameshift mutations in FAT1 cause a syndrome characterized by colobomatous-microphthalmia, ptosis, nephropathy and syndactyly.

Najim Lahrouchi, Aman George, Ilham Ratbi, Ronen Schneider, Siham C Elalaoui, Shahida Moosa, Sanita Bharti, Ruchi Sharma, Mones Abu-Asab, Felix Onojafe and 22 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. HomozygousRenal failure · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. [Research progress on monogenic inherited glomerular diseases with central nervous system symptoms].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2024
    Review
  8. Article
  9. Zebrafish model of RERE syndrome recapitulates key ophthalmic defects that are rescued by small molecule inhibitor of shh signaling.Developmental dynamics : an official publication of the American Association of Anatomists · 2023
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Ophthalmic genetics · 2022
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Role of FAT1 in health and disease.Oncology letters · 2021
    Review
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 12 institutions in 7 countries.

Najim LahrouchiAmsterdam UMC, University of Amsterdam, Heart Center, Department of Clinical and Experimental Cardiology, Amsterdam Cardiovascular Sciences, Meibergdreef 9, Amsterdam, 1105AZ, The Netherlands.
Aman GeorgeOphthalmic Genetics and Visual Function Branch, National Eye Institute, NIH, Bethesda, MD, 20892, USA.
Ilham RatbiCentre de Recherche en Génomique des Pathologies Humaines (GENOPATH), Faculté de Médecine et de Pharmacie, Mohammed V University of Rabat, 10100, Rabat, Morocco.
Ronen SchneiderDepartment of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
Siham C ElalaouiCentre de Recherche en Génomique des Pathologies Humaines (GENOPATH), Faculté de Médecine et de Pharmacie, Mohammed V University of Rabat, 10100, Rabat, Morocco.
Shahida MoosaInstitute of Human Genetics, University Medical Center Goettingen, 37073, Goettingen, Germany.
Sanita BhartiOphthalmic Genetics and Visual Function Branch, National Eye Institute, NIH, Bethesda, MD, 20892, USA.
Ruchi SharmaUnit on Ocular & Stem Cell Translational Research, National Eye Institute, NIH, Bethesda, MD, 20892, USA.
Mones Abu-AsabSection of Histopathology, National Eye Institute, NIH, Bethesda, MD, 20892, USA.
Felix OnojafeOphthalmic Genetics and Visual Function Branch, National Eye Institute, NIH, Bethesda, MD, 20892, USA.
Najlae AdadiCentre de Recherche en Génomique des Pathologies Humaines (GENOPATH), Faculté de Médecine et de Pharmacie, Mohammed V University of Rabat, 10100, Rabat, Morocco.
Elisabeth M LodderAmsterdam UMC, University of Amsterdam, Heart Center, Department of Clinical and Experimental Cardiology, Amsterdam Cardiovascular Sciences, Meibergdreef 9, Amsterdam, 1105AZ, The Netherlands.ORCID http://orcid.org/0000-0001-6017-3796
Fatima-Zahra LaarabiDépartement de génétique médicale, Institut National d'Hygiène, BP 769 Agdal, 10090, Rabat, Morocco.
Yassine LamsyahService d'Ophtalmologie B, Hôpital des Spécialités, CHU Rabat, Faculté de médecine et de Pharmacie, Mohammed V University of Rabat, 10100, Rabat, Morocco.
Hamza ElorchService d'Ophtalmologie B, Hôpital des Spécialités, CHU Rabat, Faculté de médecine et de Pharmacie, Mohammed V University of Rabat, 10100, Rabat, Morocco.
Imane ChebbarService d'Ophtalmologie B, Hôpital des Spécialités, CHU Rabat, Faculté de médecine et de Pharmacie, Mohammed V University of Rabat, 10100, Rabat, Morocco.
Alex V PostmaAmsterdam UMC, University of Amsterdam, Department of Anatomy, Embryology & Physiology, Amsterdam Cardiovascular Sciences, Meibergdreef 9, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0003-4874-2487
Vassilios LougarisPediatrics Clinic and Institute for Molecular Medicine "A. Nocivelli", Department of Clinical and Experimental Sciences, University of Brescia and ASST-Spedali Civili of Brescia, 25123, Brescia, Italy.
Alessandro PlebaniPediatrics Clinic and Institute for Molecular Medicine "A. Nocivelli", Department of Clinical and Experimental Sciences, University of Brescia and ASST-Spedali Civili of Brescia, 25123, Brescia, Italy.
Janine AltmuellerCologne Center for Genomics University of Cologne, 50931, Cologne, Germany.
Henriette KyrieleisDepartment of Pediatrics, Bethanien Hospital, Cologne, 42699, Germany.
Vardiella MeinerDepartment of Human Genetics and Metabolic Diseases, Hadassah-Hebrew University Medical Center, Jerusalem, 91120, Israel.
Helen McNeillDepartment of Developmental Biology, Washington University School of Medicine, St. Louis, 63110, MO, USA.
Kapil BhartiUnit on Ocular & Stem Cell Translational Research, National Eye Institute, NIH, Bethesda, MD, 20892, USA.
Stanislas LyonnetLaboratory of embryology and genetics of human malformation, Institut National de la Santé et de la Recherche Médicale (INSERM) UMR 1163, Paris Descartes-Sorbonne Paris Cité University, Institut Imagine, Paris, 75015, France.
Bernd WollnikInstitute of Human Genetics, University Medical Center Goettingen, 37073, Goettingen, Germany.
Alexandra Henrion-CaudeINSERM UMR-781, Département de Génétique, Hôpital Necker-Enfants Malades, Assistance Publique Hôpitaux de Paris (APHP), Paris, 75015, France.
Amina BerrahoService d'Ophtalmologie B, Hôpital des Spécialités, CHU Rabat, Faculté de médecine et de Pharmacie, Mohammed V University of Rabat, 10100, Rabat, Morocco.
Friedhelm HildebrandtDepartment of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA.ORCID http://orcid.org/0000-0002-7130-0030
Connie R BezzinaAmsterdam UMC, University of Amsterdam, Heart Center, Department of Clinical and Experimental Cardiology, Amsterdam Cardiovascular Sciences, Meibergdreef 9, Amsterdam, 1105AZ, The Netherlands. c.r.bezzina@amc.uva.nl.
Brian P BrooksOphthalmic Genetics and Visual Function Branch, National Eye Institute, NIH, Bethesda, MD, 20892, USA. brooksb@nei.nih.gov.
Abdelaziz SefianiCentre de Recherche en Génomique des Pathologies Humaines (GENOPATH), Faculté de Médecine et de Pharmacie, Mohammed V University of Rabat, 10100, Rabat, Morocco. sefianigen@hotmail.com.
Mohammed V University · MANational Eye Institute · USAmsterdam Neuroscience · NLBoston Children's Hospital · USUniversity of Brescia · ITHôpital Necker-Enfants Malades · FRInserm · FRInstitut National d'Hygiène du Maroc · MAKrankenhaus Bethanien · DEUniversity of Cologne · DEUniversity of Göttingen · DEWashington University in St. Louis · US

Funding

Identification and function of new genes causing childhood nephrotic syndromeR01DK076683 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HILDEBRANDT, FRIEDHELM · 2007 to 2021
$5.3M
NIDDK NIH HHS R01 DK076683NIH HHS DK076683
6 · The paper itself

Abstract

A failure in optic fissure fusion during development can lead to blinding malformations of the eye. Here, we report a syndrome characterized by facial dysmorphism, colobomatous microphthalmia, ptosis and syndactyly with or without nephropathy, associated with homozygous frameshift mutations in FAT1. We show that Fat1 knockout mice and zebrafish embryos homozygous for truncating fat1a mutations exhibit completely penetrant coloboma, recapitulating the most consistent developmental defect observed in affected individuals. In human retinal pigment epithelium (RPE) cells, the primary site for the fusion of optic fissure margins, FAT1 is localized at earliest cell-cell junctions, consistent with a role in facilitating optic fissure fusion during vertebrate eye development. Our findings establish FAT1 as a gene with pleiotropic effects in human, in that frameshift mutations cause a severe multi-system disorder whereas recessive missense mutations had been previously associated with isolated glomerulotubular nephropathy.

Indexed as

AdolescentAdultAnimalsBlepharoptosisCadherinsCells, CulturedChildChild, PreschoolColobomaDNA Mutational AnalysisEmbryo, MammalianExome SequencingEyeFacial BonesFemaleFrameshift MutationCadherinsfat1a protein, zebrafishFAT1 protein, humanfat1 protein, mouseZebrafish Proteins

Identifiers

PMID30862798
PMCPMC6414540
OpenAlexW2934900717

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.